Apotex to Participate in the Jefferies Global Healthcare Conference 2024

TORONTO, June 4, 2024 /PRNewswire/ - Apotex Inc. ("Apotex"), Canada's largest pharmaceutical company, announced that Allan Oberman, President & CEO, will be presenting at the Jefferies Healthcare Conference on Wednesday, June 5th, 2024 at 9:00 am EST in New York, NY.

About Apotex

Apotex is a Canadian-based global health company with a portfolio of generic, biosimilar, and innovative branded pharmaceutical products that meet a broad set of patient and consumer needs. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico and India, and an extensive international distribution network, Apotex has led the Canadian generic pharmaceutical market for decades. As the largest Canadian-based pharmaceutical company and a health partner of choice for pharmaceutical licensing and product acquisitions, Apotex delivers high-quality, affordable and complex medicines around the world. Learn more about Apotex's commitment over the last 50 years to improve everyday access to innovative medicines and health products at www.apotex.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/apotex-to-participate-in-the-jefferies-global-healthcare-conference-2024-302162842.html

SOURCE Apotex Inc.